December 5, 2019

BioLineRx Announces Preliminary Phase 2a Data from Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Second Line Patients With Metastatic Pancreatic Cancer

November 26, 2019

BioLineRx to Host Investor and Analyst Breakfast Meeting on December 5, 2019 in New York

November 11, 2019

BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update